首页> 外文OA文献 >Pharmacological profile and clinical trial results of a long-acting, once weekly human GLP-1 receptor agonist Dulaglutide (Genetical Recombination)

【2h】

Pharmacological profile and clinical trial results of a long-acting, once weekly human GLP-1 receptor agonist Dulaglutide (Genetical Recombination)

机译：长效的药理型材和临床试验结果，每周人GLP-1受体激动剂杜拉蛋白（遗传重组）

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Chihiro Tamaki; Masakazu Takeuchi; Noriyuki Iwamoto; Wolfgang Glaesner;
展开▼
作者单位

展开▼
年度 2015
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Potential of albiglutide, a long-acting GLP-1 receptor agonist, in type 2 diabetes: a randomized controlled trial exploring weekly, biweekly, and monthly dosing. [J] . Rosenstock J, Reusch J, Bush M Diabetes care . 2009,第10期

机译：长效GLP-1受体激动剂albiglutide在2型糖尿病中的潜力：每周，每两周和每月服用一次的随机对照试验。
2. Chronic Toxicity and Carcinogenicity Studies of the Long-Acting GLP-1 Receptor Agonist Dulaglutide in Rodents [J] . Byrd Richard A., Sorden Steven D., Ryan Thomas, Endocrinology . 2015,第7期

机译：长效GLP-1受体激动剂杜拉鲁肽对啮齿动物的慢性毒性和致癌性研究
3. Drug update Dulaglutide: a once-weekly GLP-1 receptor agonist for type 2 diabetes [J] . KIRSTEN E. NEAL, GREGORY R. FULCHER Medicine today . 2019,第5期

机译：药物更新Dulaglutide：2型糖尿病的一次每周GLP-1受体激动剂
4. Discovery and Structural Optimization of High Affinity Co-Agonists at the Glucagon and GLP-1 Receptors [C] . Tao Ma, Jonathan Day, Vasily Gelfanov American Peptide Symposium . 2009

机译：胰高血糖素和GLP-1受体的高亲和力共激剂的发现与结构优化
5. Selective GLP-1 receptor antagonists and glucagon/GLP-1 co-agonists discovered through an investigation into the structure-activity relationship in glucagon-related peptides. [D] . Patterson, James T. 2011

机译：通过研究胰高血糖素相关肽的结构-活性关系，发现了选择性的GLP-1受体拮抗剂和胰高血糖素/ GLP-1共激动剂。
6. Clinical Effectiveness and Safety of Once-Weekly GLP-1 Receptor Agonist Dulaglutide as Add-On to Metformin or Metformin Plus Insulin Secretagogues in Obesity and Type 2 Diabetes [O] . Maria Mirabelli, Eusebio Chiefari, Vera Tocci, 2021

机译：持续每周GLP-1受体激动剂杜拉蛋白作为肥胖症和2型糖尿病患者的临床效应和安全性作为二甲双胍或二甲双胍的胰岛素分泌抑制剂
7. Potential of Albiglutide, a Long-Acting GLP-1 Receptor Agonist, in Type 2 Diabetes: A randomized controlled trial exploring weekly, biweekly, and monthly dosing [O] . Rosenstock, Julio, Reusch, Jane, Bush, Mark, 2009

机译：长效GLP-1受体激动剂Albiglutide在2型糖尿病中的潜力：每周，每两周和每月服用一次的随机对照试验

Pharmacological profile and clinical trial results of a long-acting, once weekly human GLP-1 receptor agonist Dulaglutide (Genetical Recombination)

著录项

引文网络

相似文献

相关主题

期刊订阅